Position in INVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$47,161,110
+$4,891,676 QoQ
Shares Held
2,024,082
-4.3% QoQ
Ownership
2.74%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 58.35358530257899.ToString("F0")%
Shared 0.ToString("F0")%
None 41.646414697421.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SYSTEMATIC FINANCIAL MANAGEMENT LP holds $191,675,128 across 6 Biotechnology names. INVA ranks #2 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
407,114 | $76,964,901 | |
| 2 | INVA |
Innoviva, Inc.
This page
|
2,024,082 | $47,161,110 | |
| 3 | EXEL |
Exelixis, Inc.
|
709,127 | $30,414,456 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
747,515 | $18,508,470 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
255,354 | $14,424,947 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,484,539 | $4,201,244 |
All Filings in INVA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,161,110 | 2,024,082 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $42,269,434 | 2,114,529 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $38,623,661 | 2,116,365 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,368,825 | 2,059,175 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $37,551,816 | 2,071,253 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $35,204,346 | 2,029,069 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $38,215,899 | 1,979,073 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $30,986,816 | 1,889,440 | Shares | Defined | 2024-08-16 | |
| 2024-03-31 | $31,598,554 | 2,073,396 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $34,741,212 | 2,165,911 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,612,644 | 2,202,667 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,202,869 | 2,215,465 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $25,217,718 | 2,241,575 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,884,206 | 1,953,525 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $21,347,783 | 1,838,741 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,401,793 | 1,449,986 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,871,551 | 975,274 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $14,446,409 | 837,473 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,343,158 | 738,669 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,102,070 | 529,610 | Shares | Defined | 2021-08-12 | |
| 2020-06-30 | $297,214 | 21,260 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $371,557 | 31,595 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||